Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 12/27/2025Telix Advances Regulatory Efforts with Positive China Phase 3 Data
  • 12/27/2025China Approves Novo Nordisk's Sogroya for Pediatric Growth Hormone Def...
  • 12/27/2025Zai Lab's COBENFY Approve in China for Schizophrenia
  • 12/27/2025GRIT's Next-Generation Gene-Edited TIL GT307 Receives FDA IND Approval
  • 12/27/2025NMPA Approves Amgen/UCB's Evenity for Postmenopausal Osteoporosis
  • 12/27/2025China Approves GSK's Nucala for Maintenance Treatment of Eosinophilic ...
  • 12/23/2025CSPC Announces China Approval for Daratumumab Injection
  • 12/23/2025Qilu Launches Phase 1 Trial of FIC CD3/CD20/CD79b Triple Antibody QLS2...
  • 12/23/2025T-MAXIMUM Secures FDA Approval to Advance Off-the-Shelf CAR-T Therapy
  • 12/23/2025China Approves First Global CSF-1R Inhibitor Pimicotinib for Rare Join...
  • 12/22/2025Alphamab's IND for PD-L1/VEGFR2 Bispecific ADC JSKN027 Accepted in Chi...
  • 12/22/2025Epigenic Wins FDA IND Clearance for Novel Epigenetic Therapy Targeting...
  • 12/18/2025Rona Advances Dual-Targeting siRNA RN5681 Into Clinical Development
  • 12/18/2025HUTCHMED Initiates Global Clinical Development of FIC ATTC Candidate H...
  • 12/18/2025China Grants First Global Approval to Cytokinetics' Cardiomyopathy Dru...
  • 12/18/2025Atom Thera Advances Anti-Inflammatory Pipeline With FDA Clearance for ...
  • 12/18/2025Sanofi's Aficamten Wins China Approval for Obstructive Hypertrophic Ca...
  • 12/16/2025China Approves Genzyme's Fenthosilan Sodium Injection
  • 12/16/2025InnoCare's Orelabrutinib Hits Primary Endpoint in Phase 2b Lupus Trial...
  • 12/15/2025Qilu Advances GSPT1 Degrader ADC Program, PCT Patent Reveals
  • 12/15/2025AusperBio Reports Promising Phase 2a Results for AHB-137 in Chronic He...
  • 12/15/2025Qilu Wins Approval for China's First Fully Human Anti-EGFR Antibody
  • 12/15/2025InnoCare Secures NMPA Approval for Pan-TRK Inhibitor Zurletrectinib
  • 12/12/2025CMS's NDA for Innovative Stroke Drug Y-3 for Injection Accepted in Ch...
  • 12/12/2025Ascletis' Acne Drug Denifanstat Enters NMPA Review After NDA Acceptanc...
  • 12/12/2025InnoCare Pharma Wins NMPA Approval for Next-Gen TRK Inhibitor Zurletre...
  • 12/11/2025China Approves Sanofi's Qfitlia (fitusiran) for Severe Hemophilia
  • 12/11/2025Forward Pharma Reports Promising Early Data for Oral SERD FWD1802
  • 12/11/2025Hengrui Launches Phase 1/2 Trial of Subcutaneous PD-1/VEGF BsAb SHR-46...
  • 12/11/2025Kelingyuan Reports Early Tumor Responses for Novel HER2-Targeted ADC S...
  • Page:1/21 Total number of articles:609: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group